RenBio Announces New Awards to Support Continued Development of Its Novel, DNA-Based MYO Technology™ Platform for Antiviral Applications ...Middle East

$2.9 Million Received From Wellcome for DNA-Based Delivery of Antiviral Antibodies for Zika and Influenza Prevention, Focusing on Preclinical Development of a Potent Anti-Zika Antibody and Optimizing Antibody Cocktail Delivery $749,000 Contract from the BARDA Flexible and Strategic...

Hence then, the article about renbio announces new awards to support continued development of its novel dna based myo technology platform for antiviral applications was published today ( Thursday 25/07/2024 - 02:38 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( RenBio Announces New Awards to Support Continued Development of Its Novel, DNA-Based MYO Technology™ Platform for Antiviral Applications )

Also on site :

• Investigation underway after 16-year-old shot and killed in north suburbs
• Nick Cannon Calls the Democratic Party the ‘Party of the KKK’ and Says ‘I F— With Trump’
• Jamie Dornan Reveals Passion for Collecting Rocks That Look Like Potatoes in ‘SNL U.K.’ Monologue: ‘This Isn’t a Joke. God Knows, I Wish It Was’